Clear-Cell Carcinoma Developing in Remnant Ovary After Hysterectomy and Bilateral Salpingo-Oophorectomy for Endometriosis

In: Journal of Gynecologic Surgery · 2014 · vol. 30(2) , pp. 114–117 · doi:10.1089/gyn.2013.0089 · W2148467585
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This case report describes the first instance of primary ovarian clear cell carcinoma developing in an ovarian remnant 3 years after hysterectomy and bilateral salpingo-oophorectomy for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: Ovarian remnant syndrome is a rare gynecologic complication, most induced by difficult bilateral salpingo-oophorectomy (BSO) with the residual ovarian tissue on the pelvic wall. The residual ovarian tissue may eventually cause malignant development with mostly endometrioid adenocarcinoma. This is the first report of a case with a primary ovarian clear cell carcinoma developing in the ovarian remnant. Case: A 48-year-old woman, gravida 2, para 2, developed a primary ovarian clear cell carcinoma diagnosed through a routine gynecologic examination 3 years and 5 months after total abdominal hysterectomy and BSO for endometriosis. Results: The patient received six additional courses of systemic chemotherapy and, as of this writing, is still receiving intensive care. Conclusions: On BSO after pelvic inflammatory disease, multiple previous surgery, or endometriosis, the possibility of ovarian remnant syndrome should be borne in mind, and particular care must be taken to prevent the development of pelvic masses. When managing pelvic masses suspected of malignancy after BSO, one must be aware of the possible role of endometriosis in the development of a malignancy. (J GYNECOL SURG 30:114)

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK